Histone Methyltransferase Suv39h1 Represses MyoD-stimulated Myogenic Differentiation

Overview

Journal EMBO J

Specialties Biotechnology
Molecular Biology

Date 2006 Jul 22

PMID 16858404

Citations 71

Authors

Asoke K Mal

Affiliations

Soon will be listed here.

Abstract

Suv39h1 is a histone H3 lysine-9 (H3-K9) specific methyltransferase (HMT) that is associated with gene silencing through chromatin modification. The transition from proliferation into differentiation of muscle cell is accompanied by transcriptional activation of previously silent muscle genes. I report Suv39h1 interaction with myogenic regulator MyoD in proliferating muscle cells and its HMT activity, which is associated with MyoD, diminishes as differentiation proceeds. The Suv39h1-MyoD complex was detected on the chromatin regulatory regions of a silent differentiation signal muscle gene myogenin and that Suv39h1 presence correlated with H3-K9 methylation. Increased Suv39h1 expression repressed MyoD-dependent muscle gene expression and this property required its HMT activity. This repression required Suv39h1 association with MyoD as well as sustained methylation of H3-K9 on myogenin promoter. Suv39h1 was required for muscle gene repression because its abrogation by siRNA activates these gene expressions by MyoD. These findings suggest that Suv39h1 presence in association with MyoD on the promoter of muscle genes silences gene transcription, providing a necessary checkpoint between proliferation and differentiation.

Citing Articles

Epigenetic control of skeletal muscle atrophy.

Liang W, Xu F, Li L, Peng C, Sun H, Qiu J Cell Mol Biol Lett. 2024; 29(1):99.

PMID: 38978023 PMC: 11229277. DOI: 10.1186/s11658-024-00618-1.

Lysine-specific methyltransferase Set7/9 in stemness, differentiation, and development.

Daks A, Parfenyev S, Shuvalov O, Fedorova O, Nazarov A, Melino G Biol Direct. 2024; 19(1):41.

PMID: 38812048 PMC: 11137904. DOI: 10.1186/s13062-024-00484-z.

PHF2 regulates sarcomeric gene transcription in myogenesis.

Fukushima T, Hasegawa Y, Kuse S, Fujioka T, Nikawa T, Masubuchi S PLoS One. 2024; 19(5):e0301690.

PMID: 38701072 PMC: 11068198. DOI: 10.1371/journal.pone.0301690.

The Wnt-pathway corepressor TLE3 interacts with the histone methyltransferase KMT1A to inhibit differentiation in Rhabdomyosarcoma.

Kalita B, Sahu S, Bharadwaj A, Panneerselvam L, Martinez-Cebrian G, Agarwal M Oncogene. 2024; 43(7):524-538.

PMID: 38177411 DOI: 10.1038/s41388-023-02911-3.

Zeb1 and Tle3 are trans-factors that differentially regulate the expression of myosin heavy chain-embryonic and skeletal muscle differentiation.

Kumar P, Zehra A, Saini M, Mathew S FASEB J. 2023; 37(8):e23074.

PMID: 37392376 PMC: 7615532. DOI: 10.1096/fj.202201698RR.

References

Berkes C, Bergstrom D, Penn B, Seaver K, Knoepfler P, Tapscott S . Pbx marks genes for activation by MyoD indicating a role for a homeodomain protein in establishing myogenic potential. Mol Cell. 2004; 14(4):465-77. DOI: 10.1016/s1097-2765(04)00260-6. View

Budanov A, Sablina A, Feinstein E, Koonin E, Chumakov P . Regeneration of peroxiredoxins by p53-regulated sestrins, homologs of bacterial AhpD. Science. 2004; 304(5670):596-600. DOI: 10.1126/science.1095569. View

Davis R, Weintraub H, Lassar A . Expression of a single transfected cDNA converts fibroblasts to myoblasts. Cell. 1987; 51(6):987-1000. DOI: 10.1016/0092-8674(87)90585-x. View

Weintraub H, Dwarki V, Verma I, Davis R, Hollenberg S, Snider L . Muscle-specific transcriptional activation by MyoD. Genes Dev. 1991; 5(8):1377-86. DOI: 10.1101/gad.5.8.1377. View

Andres V, Walsh K . Myogenin expression, cell cycle withdrawal, and phenotypic differentiation are temporally separable events that precede cell fusion upon myogenesis. J Cell Biol. 1996; 132(4):657-66. PMC: 2199863. DOI: 10.1083/jcb.132.4.657. View

Gerber A, Klesert T, Bergstrom D, Tapscott S . Two domains of MyoD mediate transcriptional activation of genes in repressive chromatin: a mechanism for lineage determination in myogenesis. Genes Dev. 1997; 11(4):436-50. DOI: 10.1101/gad.11.4.436. View

Caretti G, Di Padova M, Micales B, Lyons G, Sartorelli V . The Polycomb Ezh2 methyltransferase regulates muscle gene expression and skeletal muscle differentiation. Genes Dev. 2004; 18(21):2627-38. PMC: 525543. DOI: 10.1101/gad.1241904. View

Shi Y, Lan F, Matson C, Mulligan P, Whetstine J, Cole P . Histone demethylation mediated by the nuclear amine oxidase homolog LSD1. Cell. 2004; 119(7):941-53. DOI: 10.1016/j.cell.2004.12.012. View

Blais A, Tsikitis M, Acosta-Alvear D, Sharan R, Kluger Y, Dynlacht B . An initial blueprint for myogenic differentiation. Genes Dev. 2005; 19(5):553-69. PMC: 551576. DOI: 10.1101/gad.1281105. View

10.

de la Serna I, Ohkawa Y, Berkes C, Bergstrom D, Dacwag C, Tapscott S . MyoD targets chromatin remodeling complexes to the myogenin locus prior to forming a stable DNA-bound complex. Mol Cell Biol. 2005; 25(10):3997-4009. PMC: 1087700. DOI: 10.1128/MCB.25.10.3997-4009.2005. View

11.

Berkes C, Tapscott S . MyoD and the transcriptional control of myogenesis. Semin Cell Dev Biol. 2005; 16(4-5):585-95. DOI: 10.1016/j.semcdb.2005.07.006. View

12.

Naya F, Olson E . MEF2: a transcriptional target for signaling pathways controlling skeletal muscle growth and differentiation. Curr Opin Cell Biol. 1999; 11(6):683-8. DOI: 10.1016/s0955-0674(99)00036-8. View

13.

Sartorelli V, Puri P, Hamamori Y, Ogryzko V, Chung G, Nakatani Y . Acetylation of MyoD directed by PCAF is necessary for the execution of the muscle program. Mol Cell. 2000; 4(5):725-34. DOI: 10.1016/s1097-2765(00)80383-4. View

14.

Sabourin L, Rudnicki M . The molecular regulation of myogenesis. Clin Genet. 2000; 57(1):16-25. DOI: 10.1034/j.1399-0004.2000.570103.x. View

15.

Mal A, Chattopadhyay D, Ghosh M, Poon R, Hunter T, Harter M . p21 and retinoblastoma protein control the absence of DNA replication in terminally differentiated muscle cells. J Cell Biol. 2000; 149(2):281-92. PMC: 2175169. DOI: 10.1083/jcb.149.2.281. View

16.

Firestein R, Cui X, Huie P, Cleary M . Set domain-dependent regulation of transcriptional silencing and growth control by SUV39H1, a mammalian ortholog of Drosophila Su(var)3-9. Mol Cell Biol. 2000; 20(13):4900-9. PMC: 85941. DOI: 10.1128/MCB.20.13.4900-4909.2000. View

17.

Rea S, Eisenhaber F, OCarroll D, Strahl B, Sun Z, Schmid M . Regulation of chromatin structure by site-specific histone H3 methyltransferases. Nature. 2000; 406(6796):593-9. DOI: 10.1038/35020506. View

18.

Lu J, McKinsey T, Zhang C, Olson E . Regulation of skeletal myogenesis by association of the MEF2 transcription factor with class II histone deacetylases. Mol Cell. 2000; 6(2):233-44. DOI: 10.1016/s1097-2765(00)00025-3. View

19.

Mal A, Sturniolo M, Schiltz R, Ghosh M, Harter M . A role for histone deacetylase HDAC1 in modulating the transcriptional activity of MyoD: inhibition of the myogenic program. EMBO J. 2001; 20(7):1739-53. PMC: 145490. DOI: 10.1093/emboj/20.7.1739. View

20.

Tachibana M, Sugimoto K, Fukushima T, Shinkai Y . Set domain-containing protein, G9a, is a novel lysine-preferring mammalian histone methyltransferase with hyperactivity and specific selectivity to lysines 9 and 27 of histone H3. J Biol Chem. 2001; 276(27):25309-17. DOI: 10.1074/jbc.M101914200. View